# Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients

> **NCT02281669** · — · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Cutaneous Leishmaniasis

## Interventions

- **DRUG:** Pentostam

## Key facts

- **NCT ID:** NCT02281669
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11
- **Primary completion:** 2016-11
- **Final completion:** 2017-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2014-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02281669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02281669, "Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT02281669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*